$4.02
2.29% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US14161W1053
Symbol
CDLX

Cardlytics, Inc. Stock price

$4.02
+0.14 3.61% 1M
-5.38 57.23% 6M
-5.19 56.35% YTD
-3.43 46.04% 1Y
-68.52 94.46% 3Y
-50.76 92.66% 5Y
-9.35 69.93% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.09 2.29%
ISIN
US14161W1053
Symbol
CDLX

Key metrics

Market capitalization $204.31m
Enterprise Value $359.25m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.22
P/S ratio (TTM) P/S ratio 0.70
P/B ratio (TTM) P/B ratio 2.90
Revenue growth (TTM) Revenue growth -3.00%
Revenue (TTM) Revenue $293.47m
EBIT (operating result TTM) EBIT $-63.05m
Free Cash Flow (TTM) Free Cash Flow $-10.58m
Cash position $66.99m
EPS (TTM) EPS $-6.11
P/E forward negative
P/S forward 0.76
EV/Sales forward 1.34
Short interest 16.70%
Show more

Is Cardlytics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Cardlytics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Cardlytics, Inc. forecast:

5x Hold
83%
1x Sell
17%

Analyst Opinions

6 Analysts have issued a Cardlytics, Inc. forecast:

Hold
83%
Sell
17%

Financial data from Cardlytics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
293 293
3% 3%
100%
- Direct Costs 163 163
8% 8%
55%
131 131
5% 5%
45%
- Selling and Administrative Expenses 113 113
7% 7%
39%
- Research and Development Expense 52 52
3% 3%
18%
-35 -35
31% 31%
-12%
- Depreciation and Amortization 28 28
7% 7%
10%
EBIT (Operating Income) EBIT -63 -63
22% 22%
-21%
Net Profit -275 -275
33% 33%
-94%

In millions USD.

Don't miss a Thing! We will send you all news about Cardlytics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cardlytics, Inc. Stock News

Neutral
Seeking Alpha
19 days ago
Cardlytics, Inc. (CDLX) Q3 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
20 days ago
ATLANTA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the third quarter ended September 30, 2024.
Neutral
GlobeNewsWire
about one month ago
ATLANTA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its financial results for the third quarter ending September 30, 2024 will be released on November 6, 2024, after market close. The results will be discussed via conference call at 5:00 PM ET / 2:00 PM PT.
More Cardlytics, Inc. News

Company Profile

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Head office United States
CEO Amit Gupta
Employees 434
Founded 2008
Website www.cardlytics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today